Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients-Reference-Cited by-同舟云学术

Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients

Published:2009-02 Issue:2 Volume:337 Page:116-122
ISSN:0002-9629
Container-title:The American Journal of the Medical Sciences
language:en
Short-container-title:The American Journal of the Medical Sciences

Author:

Hsu Heng Jung,Wu Mai-Szu

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. Clinical epidemiology of cardiovascular disease in chronic renal disease;Foley;Am J Kidney Dis,1998

2. Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States;Collins;Am J Kidney Dis,2003

3. Renal replacement therapy in the United States: data from the United States Renal Data System;Agodoa;Am J Kidney Dis,1995

4. Predictors of stroke in patients receiving chronic hemodialysis;Iseki;Kidney Int,1996

5. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients;Iseki;Kidney Int,1993

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interrelationships among metabolic syndrome, bone-derived cytokines, and the most common metabolic syndrome-related diseases negatively affecting bone quality;Diabetology & Metabolic Syndrome;2024-09-06

2. Association of Markers of Bone Mineral Disease and Left Ventricular Hypertrophy in Patients of Chronic Kidney Disease;Acta Medica Bulgarica;2024-09-01

3. Treatment with Sacubitril/Valsartan Effectively Manages Hypertension and Ameliorates Left Ventricular Hypertrophy in Hemodialysis Patients;Blood Purification;2024

4. Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease;Frontiers in Endocrinology;2023-12-19

5. The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?;Clinical Kidney Journal;2023-06-27